Saturn-V-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "ASND",
  "CNTA",
  "NAMS",
  "ARGX",
  "ABVX",
  "SLN",
  "SNDX",
  "AMLX",
  "CTNM",
  "KALV",
  "MLTX",
  "COGT",
  "INZY",
  "XENE",
  "PCVX",
  "CELC",
  "CGON",
  "CRNX",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 21
Total Value: 198158284
Accession Number: 0001964437-25-000005
Form Type: 13F-HR
CIK: saturn-v-capital-management-lp
Manager Name: Saturn-V-Capital-Management-Lp

Data Enrichment

100% identified

21 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

21 positions • $198.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Inozyme Pharma, Inc.

INZY|45790W108

Shares:499.3K

Value:$454.3K

% of Portfolio:0.2% ($454.3K/$198.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Inozyme Pharma, Inc.(INZYcusip45790W108)	499.3K	QoQ -63.67% (-875.3K) YoY NEW(+499.3K)	All Managers (Combined)	$454.3K	0.2% ($454.3K/$198.2M)	QoQ -88.06% (-$3.4M) YoY NEW(+$454.3K)